Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracardiac Thrombi in Behçet's Disease: Systematic Review of 218 Patients' Clinical Characteristics and Treatments.

European cardiology·2026
Same author

Outcomes of Lobectomy Versus Sublobar Resection for Clinical Stage IA3 Non-Small Cell Lung Cancer.

The Annals of thoracic surgery·2026
Same author

Outcomes Of Neoadjuvant Chemoradiation Versus Neoadjuvant Chemotherapy For Esophageal Junction Signet Ring Cell Adenocarcinoma.

The Annals of thoracic surgery·2026
Same author

Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancer.

Advances in biomarker sciences and technology·2026
Same author

Cigarette smoke induces FASN-dependent fatty acid metabolic rewiring to drive bladder cancer progression.

Cancer letters·2026
Same author

Local Consolidative Surgery for Oligometastatic Non-Small Cell Lung Cancer With Bone Metastasis.

Annals of thoracic surgery short reports·2026

Related Experiment Videos

Multidisciplinary Management of Esophageal Cancer.

Anas M Barabrah1, Cindy M Pabon2, William Jin3

  • 1Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

JCO Oncology Practice
|June 3, 2026
PubMed
Summary
This summary is machine-generated.

Esophageal cancer (EC) management is evolving with tailored therapies. Advances in endoscopic treatments, multimodality care, and biomarker-driven strategies improve survival and quality of life for esophageal cancer patients.

Related Experiment Videos

Area of Science:

  • Oncology
  • Gastroenterology
  • Cancer Research

Background:

  • Esophageal cancer (EC) presents significant heterogeneity and lethality.
  • Recent advancements reshape EC diagnosis, staging, and treatment paradigms.

Purpose of the Study:

  • To review current EC management strategies.
  • Emphasize stage, histology, and biomarker-directed care within a multidisciplinary framework.

Main Methods:

  • Narrative review of clinical guidelines, landmark trials, and recent evidence.
  • Focus on esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC).

Main Results:

  • Early-stage EC increasingly managed with endoscopic resection and ablative therapies.
  • Neoadjuvant chemoradiation for ESCC; perioperative therapy for EAC.
  • Immunotherapy and targeted agents improve outcomes in advanced/metastatic EC.

Conclusions:

  • Optimal EC management requires individualized, multidisciplinary care.
  • Integrating tumor stage, histology, molecular characteristics, and patient fitness is crucial.
  • Ongoing advances in systemic therapy, immunotherapy, and supportive care refine treatment and improve outcomes.